Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Dr Reddy's Laboratories Ltd
Operating Income
Dr Reddy's Laboratories Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Income
₹64.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Income
₹52.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
12%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Income
₹101.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
5%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Operating Income
₹39.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Operating Income
₹24.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Operating Income
₹21.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Dr Reddy's Laboratories Ltd's Operating Income?
Operating Income
64.6B
INR
Based on the financial report for Mar 31, 2024, Dr Reddy's Laboratories Ltd's Operating Income amounts to 64.6B INR.
What is Dr Reddy's Laboratories Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
26%
Over the last year, the Operating Income growth was 22%. The average annual Operating Income growth rates for Dr Reddy's Laboratories Ltd have been 25% over the past three years , 26% over the past five years .